Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease — Amir Hakim (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease
Shared by
Peter J Barnes
Imperial College London
Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease
Letter
2018
en
Authors
+4 more
AH
Amir Hakim
YK
Younis Mohd Khan
IE
Ignacio Esteban
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1999
Effect of Inhaled Budesonide on Lung Function and Airway Inflammation
Sam Lim
,
Anon Jatakanon
,
Matthias John
,
Tom Gilbey
,
Brian O’Connor
,
Kian Fan Chung
,
Peter J Barnes
Article
2001
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
Paul M. O’Byrne
,
Peter J Barnes
,
Roberto Rodríguez-Roisin
,
E Runnerström
,
Thomas Sandström
,
Klas Svensson
,
Anne E. Tattersfield
Article
2004
Effects of low‐dose dopamine on ventilation in patients with chronic obstructive pulmonary disease
Agnieszka Ciarka
,
R. Rimacchi
,
Jean Louis Vincent
,
Sonia Velez‐Roa
,
M. Dumonceaux
,
Marc Leeman
,
P van de Borne
Letter
2011
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Lethal Association
Peter J Barnes
,
Ian M. Adcock
Article
2011
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Ian M. Adcock
,
Gaetano Caramori
,
Peter J Barnes
Discussion(0)
No comments yet. Be the first to comment.